WallStreetZenWallStreetZen

NASDAQ: SAVA
Cassava Sciences Inc Stock Ownership - Who owns Cassava Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cassava Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert Christopher CookChief Operating Legal Office2025-09-3013,725$2.91
$39.94kBuy
Richard BarryPresident CEO2025-09-227,172$2.28
$16.35kBuy
Richard BarryPresident CEO2025-09-19400$2.25
$900.00Buy
Richard BarryPresident CEO2025-09-1946,908$2.29
$107.42kBuy
Richard BarryPresident CEO2025-09-185,400$2.13
$11.50kBuy
Richard BarryPresident CEO2025-09-18185,233$2.24
$414.92kBuy
James William KupiecChief Medical Officer2024-11-294,000$3.87
$15.48kSell
Eric SchoenChief Financial Officer2024-11-2959,800$3.86
$230.83kSell
Eric SchoenChief Financial Officer2024-11-292,000$3.82
$7.64kSell
Eric SchoenChief Financial Officer2024-11-2950,000$1.18
$59.00kBuy

1 of 1

SAVA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SAVA insiders and whales buy or sell their stock.

SAVA Shareholders

What type of owners hold Cassava Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eastbourne Capital Management LLC29.25%14,131,378$50.59MInsider
Remi Barbier18.27%8,827,362$31.60MInsider
Sabretooth Master Fund LP8.82%4,263,076$15.26MInsider
Black Bear Offshore Master Fund LP8.67%4,186,238$14.99MInsider
Vanguard Group Inc4.49%2,170,072$7.77MInstitution
Armistice Capital LLC3.42%1,651,340$5.91MInsider
Blackrock Inc3.20%1,545,907$5.53MInstitution
Sanford Robertson2.35%1,135,851$4.07MInsider
Two Sigma Advisers LP2.04%983,600$3.52MInstitution
Jpmorgan Chase Co1.57%757,061$2.71MInstitution

1 of 3

SAVA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SAVA25.35%73.20%Net BuyingNet Buying
TNXP8.29%91.71%Net BuyingNet Buying
VOR71.68%28.32%Net SellingNet Selling
ACHV71.66%28.34%Net SellingNet Selling
CYBN36.01%0.00%
View Top Biotech Stocks

Cassava Sciences Stock Ownership FAQ

Who owns Cassava Sciences?

Cassava Sciences (NASDAQ: SAVA) is owned by 25.35% institutional shareholders, 73.20% Cassava Sciences insiders, and 1.45% retail investors. Eastbourne Capital Management LLC is the largest individual Cassava Sciences shareholder, owning 14.13M shares representing 29.25% of the company. Eastbourne Capital Management LLC's Cassava Sciences shares are currently valued at $48.33M.

If you're new to stock investing, here's how to buy Cassava Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.